Eric Lefkofsky Co-founded the company Tempus with Brad Keywell and he currently operates as the company’s CEO. The technology behind Tempus is being used to compile large amounts of molecular and genomic data into a single database that can be used by doctors to create more precise treatments for cancer patients. Eric is well-known in the business industry as a successful entrepreneur today, having started several of his own companies before Tempus. The majority of people know him from his majority successful Groupon platform, which offers coupons to customers around the world for better deals on everyday things.
Advancements are coming to the fields of healthcare and technology on a regular basis, but there are still many things that are under par that need some serious focus. This was the reason behind Eric’s desire to start up Tempus for cancer treatments. Eric saw cancers disastrous effects up close in his personal life and he noticed the lack of proper data organization and patient dedicated treatments. Eric has stated that data is one of the biggest problems currently facing the medical world. Eric Lefkofsky has been working on structuring data for more than 2 decades, so he knew there was technology available that would make accumulating medical data possible while simultaneously organizing it and bringing it all together.
With the latest rounds of funding over, Tempus has had more than 130 million dollars raised in funding since first starting up in 2015. Eric has said he is willing to personally invest more than 100 million into Tempus to make sure the company can complete its goal. Since Tempus already has the technology it needs to structure and compile data, Eric is working on building a data set. Once this is completed, the end result will be more precise patient information for doctors to use in their cancer treatments for patients around the globe. In the future, Eric believes Tempus will focus on more than just cancer data, but data from many other diseases as well.
To know more click: here.